Symbol       Canada   US  

Company Profile



Galmed Pharmaceuticals Ltd.
Symbol: NASDAQ : GLMD
Email:
Website: www.galmedgroup.com
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs. Galmed believes that its product candidate, aramchol, has the potential to be a disease modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-Hepatitis, or NASH, which is a chronic disease that Galmed believes constitutes a large unmet medical need.
 
GLMD Discussion Forums
Seeking Alpha
Silicon Investor
StockHouse
Yahoo

Live Discussion of GLMD


Search by Symbol       Canada   US  


Top